Form 4: Glaukos Corp President & COO Joseph E. Gilliam Reports Stock Option Exercise and Sale
SEC Form 4
Joseph E. Gilliam, President & COO of Glaukos Corporation, exercised stock options and sold shares of common stock on May 2, 2024, according to a Form 4 filing with the SEC.
Summary
- On May 2, 2024, Joseph E. Gilliam, the President & COO of Glaukos Corporation, exercised stock options to acquire 2,059 shares of common stock at a price of $69.30 per share.
- Simultaneously, Gilliam sold a total of 2,059 shares in multiple transactions at weighted average prices ranging from $104.43 to $107.58.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2023.
- Following these transactions, Gilliam directly owns 101,845 shares of Glaukos common stock, which includes 76,419 restricted stock units that have not yet vested.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing simply reports transactions executed under a pre-existing trading plan. There's no indication of positive or negative sentiment towards the company's prospects.
Positives
- The exercise of stock options indicates confidence in the company's future prospects.
- The sales were conducted under a pre-arranged trading plan, suggesting they were not based on insider information.
Industry Context
Insider transactions are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future prospects. Rule 10b5-1 plans are commonly used to allow insiders to sell shares without being accused of trading on non-public information.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| 2019-03-14 | Date the stock option was granted with a four-year vesting schedule. |
| 2023-03-07 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 2024-05-02 | Date of the stock option exercise and sale of shares. |
| 2024-05-06 | Date of the signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.